Compound class:
Antibody
Comment: BsAb (CD89-CD20) is a bi-valent antibody that binds tumour-expressed CD20 and FcαRI (CD89) on myeloid cells [1].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
| Immunopharmacology Comments |
| BsAb (CD89-CD20) is a bispecific mAb designed to show that recruiting CD89-expressing immune effector cells (macrophages and neutrophils) to tumour cells is an effective immuno-oncology strategy. |
